Apigenin Potentiates Glucose-stimulated Insulin Secretion Through the Pka-mek Kinase Signaling Pathway Independent of K-atp Channels

dc.contributor.authorShahab, Falak
dc.contributor.authorHameed, Abdul
dc.contributor.authorAli, Akhtar
dc.contributor.authorImad, Rehan
dc.contributor.authorHafizur, Rahman M.
dc.date.accessioned2025-08-10T09:45:59Z
dc.date.available2025-08-10T09:45:59Z
dc.date.issued2024-06-20
dc.description.abstractAim: Apigenin, a natural bioflavonoid, is reported as an anti-diabetic agent since it possesses the ability to inhibit α-glucosidase activity, cause stimulation of insulin action and secretion, manage ROS, and prevent diabetes complications. Apigenin was identified as a new insulin secretagogue that enhances glucose-stimulated insulin secretion and seems like a better antidiabetic drug candidate. Here we explored the insulinotropic mechanism(s) of apigenin in vitro in mice islets and in vivo in diabetic rats. Methods: Size-matched pancreatic islets were divided into groups and incubated in the presence or absence of apigenin and agonists or antagonists of major insulin signaling pathways. The secreted insulin was measured by ELISA. The intracellular cAMP was estimated by cAMP acetylation assay. The acute and chronic effects of apigenin were evaluated in diabetic rats. Results: apigenin dose-dependently enhanced insulin secretion in isolated mice islets, and its insulinotropic effect was exerted at high glucose concentrations distinctly different from glibenclamide. Furthermore, apigenin amplified glucose-induced insulin secretion in depolarized and glibenclamide-treated islets. Apigenin showed no effect on intracellular cAMP concentration; however, an additive effect was observed by apigenin in both forskolin and IBMX-induced insulin secretion. Interestingly, H89, a PKA inhibitor, and U0126, a MEK kinase inhibitor, significantly inhibited apigenin-induced insulin secretion; however, no significant effect was observed by using ESI-05, an epac2 inhibitor. Apigenin improved glucose tolerance and increased glucose-stimulated plasma insulin levels in diabetic rats. Apigenin also lowered blood glucose in diabetic rats upon chronic treatment. Conclusion: Apigenin exerts glucose-stimulated insulin secretion by modulating the PKA-MEK kinase signaling cascade independent of K-ATP channels.
dc.identifier.otherhttp://dspace.daffodilvarsity.edu.bd:8080/handle/123456789/13911
dc.identifier.urihttp://dspace.daffodilvarsity.edu.bd:8080/handle/123456789/13911
dc.language.isoen_US
dc.publisherElsevier
dc.sourceDIU Institutional Repository
dc.subjectInsulin secretion
dc.subjectProtein
dc.titleApigenin Potentiates Glucose-stimulated Insulin Secretion Through the Pka-mek Kinase Signaling Pathway Independent of K-atp Channels
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
1-s2.0-S0753332224008709-main.pdf.txt
Size:
41.35 KB
Format:
Adobe Portable Document Format

Collections